Angion Biomedica Stock Predictions

Healthcare > Biotechnology

Buy ANGN

*Your capital is at risk

$1.00

+0 (+0%)

At Close: Aug 31, 2023

Currently predicting for Mon, 8 Jun 2026

ANGN Prediction Chart

ANGN Predictions History

Latest community submissions for ANGN.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	May 31, 2023	$0.97 -2.22%	$0.98	V	98.78%	2
valeriy_d2002.360737	May 31, 2023	Bullish	$0.98	X	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ANGN with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ANGION BIOMEDICA CORP.

Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by